Editorial: Glargine, a new long-acting insulin analog for diabetic cats

被引:0
|
作者
Rand, J [1 ]
机构
[1] Univ Queensland, Ctr Compan Anim Hlth, Sch Vet Sci, Brisbane, Qld 4072, Australia
关键词
D O I
10.1892/0891-6640(2006)20[219:EGANLI]2.0.CO;2
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
引用
收藏
页码:219 / 220
页数:2
相关论文
共 50 条
  • [31] TREATMENT OF STREPTOZOTOCIN-DIABETIC DOGS WITH A LONG-ACTING SOMATOSTATIN ANALOG
    LIEN, EL
    GREENWOOD, J
    SARANTAKIS, D
    DIABETES, 1979, 28 (05) : 491 - 495
  • [32] Insulin glargine: Information on use of glargine in diabetic cats and a case report
    Spinnato, Maria-Cristina
    Cassetta, Elia
    Furlanello, Tommaso
    VETERINARIA, 2008, 22 (02): : 21 - +
  • [33] Reduced pharmacokinetic (PK) variability of a novel, long-acting insulin analog
    Strange, P
    McGill, J
    Mazzeo, M
    DIABETES, 1999, 48 : A103 - A103
  • [34] EFFECTS OF A LONG-ACTING ADENOSINE ANALOG ON INSULIN AND GLUCAGON-RELEASE
    SCHUTZ, W
    BACHER, S
    RABERGER, G
    WIENER KLINISCHE WOCHENSCHRIFT, 1980, 92 (20) : 730 - 733
  • [35] Development of a long-acting insulin analog using albumin fusion technology
    Duttaroy, A
    Kanakaraj, P
    Osborn, BL
    Schneider, H
    Pickeral, OK
    Chen, C
    Zhang, GY
    Kaithamana, S
    Singh, M
    Schulingkamp, R
    Crossan, D
    Bock, J
    Kaufman, TE
    Reavey, P
    Carey-Barber, M
    Krishnan, SR
    Garcia, A
    Murphy, K
    Siskind, JK
    McLean, MA
    Cheng, S
    Ruben, S
    Birse, CE
    Blondel, O
    DIABETES, 2005, 54 (01) : 251 - 258
  • [36] Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
    Thorsten Hartmann
    Sabrina Overhagen
    D. Margriet Ouwens
    Silja Raschke
    Paulus Wohlfart
    Norbert Tennagels
    Nina Wronkowitz
    Jürgen Eckel
    Cardiovascular Diabetology, 15
  • [37] NOVOSOL BASAL - PHARMACOKINETICS OF A NOVEL SOLUBLE LONG-ACTING INSULIN ANALOG
    JORGENSEN, S
    VAAG, A
    LANGKJAER, L
    HOUGAARD, P
    MARKUSSEN, J
    BRITISH MEDICAL JOURNAL, 1989, 299 (6696): : 415 - 419
  • [38] Effect of the long-acting insulin analogues glargine and degludec on cardiomyocyte cell signalling and function
    Hartmann, Thorsten
    Overhagen, Sabrina
    Ouwens, D. Margriet
    Raschke, Silja
    Wohlfart, Paulus
    Tennagels, Norbert
    Wronkowitz, Nina
    Eckel, Juergen
    CARDIOVASCULAR DIABETOLOGY, 2016, 15
  • [39] Diabetic Ketoacidosis Updates: Titratable Insulin Infusions and Long-Acting Insulin Early
    Kinney, Justin
    Baroi, Oshin
    Gharibian, Mania
    CRITICAL CARE RESEARCH AND PRACTICE, 2021, 2021
  • [40] Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin
    Wada, Tsutomu
    Azegami, Mari
    Sugiyama, Maine
    Tsuneki, Hiroshi
    Sasaoka, Toshiyasu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 81 (03) : 269 - 277